At the molecular and cellular levels, curcumin inactivates EMT cascade and affects many targets involved in melanoma initiation and progression (e.g., BCl-2, MAPKS, P21, and some microRNAs) [21], which emerge with great potential for clinical applications. This evidence concerns the gene BCL2 and melanoma.